Skip to main content
OpenTrials
Completed

NCT Number: NCT05004623

Early Feasibility Study of the "Easy Light" Fluorecence Imaging System

This is an early feasibility study to evaluate the device functionality of an open-field handheld wireless fluorecence imaging system for detection of sentinel lymph nodes in women with cervical and uterine cancers who underwent open surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IMIP - Instituo de Medicina Integral Professor Fernando Figueira

Recife, Pernambuco, 50070-550, Brazil

About this study

This study was designed to clinically evaluate the functionality of an prototype of our near-infrared fluorescence device named Easy Light. In brief, this device is an open-field handheld wireless fluorecence imaging system that allows real-time visualization of fluorescent dyes such as indocyanine green (ICG) using smartphones and tablets. The handheld is a rechargeable device responsible for excitation of the operative field with infra-red lighting and for capturing the fluorescence emitted by de fluorescent dye to be visualized via wi-fi in the smartphones and tablets using a pre-installed application software. Following the standards of near-infrared fluorescence for detection of sentinel lymph nodes in gynecological malignancies, the hypothesis was the identification of sentinel lymph nodes after lymphatic mapping by interstitial indocyanine green injection in the cervix was feasible with the use of our device named Easy Light.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with biopsy-proven cervical or uterine cancers;
  • Clinical stage I or II, according to FIGO - The International Federation of Gynecology and Obstetrics;
  • Indication for sentinel lymph node biopsy with or without complementary lymphadenectomy by her medical assistant;
  • Performance status of 0-2;
  • No synchronous malignancies or previous oncological treatments such as radiation or major abdominal surgery;
  • Absence of neuro-psychiatric disorders, apparent or confirmed infections, history of drug allergies, limiting obesity for surgery, and pregnancy or breast feeding;
  • Appropriated cardio-respiratory, hepato-renal and hematological reserves;
  • Signing of the Consent Form.

Exclusion criteria

  • Perioperative impossibility to inject the fluorescent dye indocyanine green in the cervical region due to any locorregional reason.

Treatment and study plan

Sentinel Lymph Node Biopsy

Device

Detection of sentinel lymph nodes by indocyanine green (ICG) fluorescent dye technique, using a prototype of the Easy Light device.

Primary outcomes

  1. The ability to detect sentinel lymph nodes.

    Time frame: Intraoperativelly

    The ability to detect at least one sentinel lymph node per patient during open surgeries.

Sponsors and collaborators

Lead sponsor

Professor Fernando Figueira Integral Medicine Institute

Other

Registry information

Official study title

Early Feasibility Study of an Open-Field Handheld Wireless Fluorecence Imaging System for Detection of Sentinel Lymph Nodes in Women With Cervical and Uterine Cancers

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Aug 13, 2021
Registry last updated
Aug 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.